| | | |
Per Share
|
| |
Total
|
| ||||||
|
Initial public offering price
|
| | | $ | 5.00 | | | | | $ | 15,000,000 | | |
|
Underwriting discounts and commissions(1)
|
| | | $ | 0.30 | | | | | $ | 900,000 | | |
|
Proceeds to us, before expenses
|
| | | $ | 4.70 | | | | | $ | 14,100,000 | | |
| | | | | | ii | | | |
| | | | | | 1 | | | |
| | | | | | 8 | | | |
| | | | | | 10 | | | |
| | | | | | 41 | | | |
| | | | | | 43 | | | |
| | | | | | 44 | | | |
| | | | | | 45 | | | |
| | | | | | 47 | | | |
| | | | | | 49 | | | |
| | | | | | 58 | | | |
| | | | | | 69 | | | |
| | | | | | 77 | | | |
| | | | | | 86 | | | |
| | | | | | 90 | | | |
| | | | | | 92 | | | |
| | | | | | 98 | | | |
| | | | | | 101 | | | |
| | | | | | 105 | | | |
| | | | | | 109 | | | |
| | | | | | 109 | | | |
| | | | | | 109 | | | |
| | | | | | F-1 | | |
| | | |
Years Ended December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
|
Revenue
|
| | | $ | 309,920 | | | | | $ | 329,410 | | |
|
Cost of revenue
|
| | | | 182,163 | | | | | | 187,848 | | |
|
Gross margin
|
| | | | 127,757 | | | | | | 141,562 | | |
| Operating expenses: | | | | | | | | | | | | | |
|
Selling, general and administrative
|
| | | | 2,665,004 | | | | | | 368,795 | | |
|
Research and development
|
| | | | 2,578,860 | | | | | | 1,011,498 | | |
|
Total operating expenses
|
| | | | 5,243,864 | | | | | | 1,380,293 | | |
|
Loss from operations
|
| | | | (5,116,107) | | | | | | (1,238,731) | | |
| Other income (expense): | | | | | | | | | | | | | |
|
Change in fair value of SAFE liability
|
| | | | (3,493,431) | | | | | | (829,700) | | |
|
Other income
|
| | | | 80,275 | | | | | | 524 | | |
|
Loss before income taxes
|
| | | | (8,529,263) | | | | | | (2,067,907) | | |
|
Income tax expense
|
| | | | — | | | | | | (1,735) | | |
|
Net loss
|
| | | $ | (8,529,263) | | | | | $ | (2,069,642) | | |
| Per share information: | | | | | | | | | | | | | |
|
Net loss per share of common stock, basic and diluted(1)
|
| | | $ | (2.46) | | | | | $ | (2.68) | | |
|
Weighted average common shares outstanding, basic and diluted(1)
|
| | | | 3,461,565 | | | | | $ | 772,351 | | |
|
Pro forma net loss per share attributable to common stockholders, basic and diluted(2)
|
| | | $ | (0.99) | | | | | | | | |
|
Pro forma weighted-average shares outstanding, basic and diluted, basic and diluted(2)
|
| | | | 5,097,353 | | | | | | | | |
| | | |
As of December 31, 2025
|
| |||||||||||||||
| | | |
Actual
|
| |
Pro Forma(2)
|
| |
Pro Forma as
Adjusted(3) |
| |||||||||
| Balance Sheet Data: | | | | | | | | | | | | | | | | | | | |
|
Cash and cash equivalents
|
| | | $ | 9,283,566 | | | | | | 12,783,566 | | | | | $ | 25,363,566 | | |
|
Working capital(1)
|
| | | | 8,211,846 | | | | | | 11,711,846 | | | | | | 24,291,846 | | |
|
Total assets
|
| | | | 10,336,680 | | | | | | 13,836,680 | | | | | | 25,944,961 | | |
|
Total liabilities
|
| | | | 1,263,466 | | | | | | 1,263,466 | | | | | | 1,263,466 | | |
|
Total convertible preferred stock
|
| | | | 19,013,673 | | | | | | — | | | | | | — | | |
|
Total stockholders’ equity (deficit)
|
| | | | (9,940,459) | | | | | | 12,573,214 | | | | | | 24,681,495 | | |
| | | |
As of December 31, 2025
|
| |||||||||||||||
| | | |
Actual
|
| |
Pro forma
|
| |
Pro forma as
adjusted |
| |||||||||
| | | |
(in thousands except share and per share data)
|
| |||||||||||||||
|
Cash and cash equivalents
|
| | | $ | 9,283,566 | | | | | $ | 12,783,566 | | | | | $ | 25,363,566 | | |
|
Series A Convertible Preferred Stock, $0.00001 par value
per share: 4,358,597 shares authorized, actual, 3,661,083 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted |
| | | | 19,013,673 | | | | | | — | | | | | | — | | |
| Shareholders’ equity (deficit): | | | | | | | | | | | | | | | | | | | |
|
Preferred stock, $0.00001 par value per share; no shares authorized, issued or outstanding, actual; 10,000,000 shares authorized and no shares issued or outstanding, pro forma and pro forma as adjusted
|
| | | | — | | | | | | — | | | | | | | | |
|
Common stock, $0.00001 par value per share: 25,000,000
shares authorized, actual, 1,410,975 shares issued and 911,255 outstanding, actual; 25,000,000 shares authorized, pro forma 9,348,579 shares issued and outstanding, pro forma; 200,000,000 shares authorized, pro forma as adjusted; 12,348,579 shares issued and outstanding, pro forma as adjusted |
| | | | 10 | | | | | | 94 | | | | | | 124 | | |
|
Additional paid-in capital
|
| | | | 663,514 | | | | | | 23,177,103 | | | | | | 35,285,354 | | |
|
Accumulated other comprehensive loss
|
| | | | (4,900) | | | | | | (4,900) | | | | | | (4,900) | | |
|
Accumulated deficit
|
| | | | (10,599,083) | | | | | | (10,599,083) | | | | | | (10,599,083) | | |
|
Total shareholders’ equity (deficit)
|
| | | | (9,940,459) | | | | | | 12,573,214 | | | | | | 24,681,495 | | |
|
Total capitalization
|
| | | $ | 9,073,214 | | | | | $ | 12,573,214 | | | | | $ | 24,681,495 | | |
| |
Initial public offering price per share of our common stock
|
| | | | | | | | | $ | 5.00 | | |
| |
Historical net tangible book deficit per share as of December 31, 2025
|
| | | $ | (11.43) | | | | | | | | |
| |
Increase in historical net tangible book deficit per share attributable to the pro forma transactions described in the preceding paragraphs
|
| | | | 12.72 | | | | | | | | |
| |
Pro forma net tangible book value per share as of December 31, 2025
|
| | | | 1.29 | | | | | | | | |
| |
Increase in net tangible book value per share attributable to new investors participating
in this offering |
| | | | 0.71 | | | | | | | | |
| |
Pro forma as adjusted net tangible book value per share after giving effect to this
offering |
| | | | | | | | | | 2.00 | | |
| |
Dilution per share to new investors participating in this offering
|
| | | | | | | | | $ | 3.00 | | |
| | | |
Shares
Purchased |
| |
Total
Consideration |
| |
Weighted
Average Price Per Share |
| |||||||||||||||||||||
| | | |
Number
|
| |
Percent
|
| |
Amount
|
| |
Percent
|
| ||||||||||||||||||
|
Existing stockholders
|
| | | | 9,348,579 | | | | | | 76% | | | | | $ | 18,791,132 | | | | | | 56% | | | | | $ | 2.01 | | |
|
Investors participating in this offering
|
| | | | 3,000,000 | | | | | | 24% | | | | | $ | 15,000,000 | | | | | | 44% | | | | | $ | 5.00 | | |
|
Total
|
| | | | 12,348,579 | | | | | | 100% | | | | | $ | 33,791,132 | | | | | | 100% | | | | | $ | 2.74 | | |
| | | |
Years Ended December 31,
|
| | | | | | | |||||||||
| | | |
2025
|
| |
2024
|
| |
$ Change
|
| |||||||||
|
Revenue
|
| | | $ | 309,920 | | | | | $ | 329,410 | | | | | $ | (19,490) | | |
|
Cost of revenue
|
| | | | 182,163 | | | | | | 187,848 | | | | | | (5,685) | | |
|
Gross margin
|
| | | | 127,757 | | | | | | 141,562 | | | | | | (13,805) | | |
| Operating expenses: | | | | | | | | | | | | | | | | | | | |
|
Selling, general and administrative
|
| | | | 2,665,004 | | | | | | 368,795 | | | | | | 2,296,209 | | |
|
Research and development
|
| | | | 2,578,860 | | | | | | 1,011,498 | | | | | | 1,567,362 | | |
|
Total operating expenses
|
| | | | 5,243,864 | | | | | | 1,380,293 | | | | | | 3,863,571 | | |
|
Loss from operations
|
| | | | (5,116,107) | | | | | | (1,238,731) | | | | | | (3,877,376) | | |
| Other income (expense): | | | | | | | | | | | | | | | | | | | |
|
Change in fair value of SAFE liability
|
| | | | (3,493,431) | | | | | | (829,700) | | | | | | (2,663,731) | | |
|
Other income
|
| | | | 80,275 | | | | | | 524 | | | | | | 79,751 | | |
|
Loss before income taxes
|
| | | | (8,529,263) | | | | | | (2,067,907) | | | | | | (6,461,356) | | |
|
Income tax expense
|
| | | | — | | | | | | (1,735) | | | | | | 1,735 | | |
|
Net loss
|
| | | $ | (8,529,263) | | | | | $ | (2,069,642) | | | | | $ | (6,459,621) | | |
| | | |
Years Ended December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
|
Cash used in operating activities
|
| | | $ | (4,622,351) | | | | | $ | (1,046,126) | | |
|
Cash used in investing activities
|
| | | | (246,993) | | | | | | (8,956) | | |
|
Cash provided by financing activities
|
| | | | 12,078,091 | | | | | | 3,011,513 | | |
|
Effect of exchange rate changes on cash
|
| | | | (6,267) | | | | | | (167) | | |
|
Net increase in cash and cash equivalents
|
| | | $ | 7,202,480 | | | | | $ | 1,956,264 | | |
|
Name
|
| |
Age
|
| |
Position
|
|
| Executive Officers: | | | | | | | |
| Serhii Kupriienko | | |
40
|
| | Chief Executive Officer (Global) and Director | |
| Alexander Fink | | |
41
|
| | Chief Executive Officer (U.S.), President and Director | |
| Brooks Ensign | | |
60
|
| | Chief Financial Officer and Treasurer | |
| Jennifer DeTrani | | |
51
|
| | Chief Legal Officer, General Counsel and Secretary | |
| Non-Employee Directors: | | | | | | | |
| Erik Prince | | |
56
|
| | Chairman | |
| Edward Antoian | | |
70
|
| | Director | |
| Amir Frenkel | | |
49
|
| | Director | |
| Derek Reisfield | | |
63
|
| | Director | |
| Philip Wagenheim | | |
55
|
| | Director | |
| Justin Zeefe | | |
48
|
| | Director | |
|
Name and Principal Position
|
| |
Year
|
| |
Salary
($) |
| |
Option
Awards ($)(1) |
| |
Non-Equity
Incentive Plan Compensation ($)(2) |
| |
All Other
Compensation ($) |
| |
Total
($) |
| ||||||||||||||||||
|
Serhii Kupriienko(3)(4)
Chief Executive Officer (Global) |
| | | | 2025 | | | | | | 166,985 | | | | | | | | | | | | | | | | | | | | | | | | 166,985 | | |
| | | | 2024 | | | | | | 92,243 | | | | | | — | | | | | | — | | | | | | — | | | | | | 92,243 | | | ||
|
Alexander Fink(3)(5)
Chief Executive Officer (U.S.) and President, and former Chief Financial Officer and Treasurer |
| | | | 2025 | | | | | | 121,897 | | | | | | | | | | | | | | | | | | | | | | | | 121,897 | | |
| | | | 2024 | | | | | | 16,500 | | | | | | — | | | | | | — | | | | | | — | | | | | | 16,500 | | | ||
| | | |
Option Awards(1)
|
| |||||||||||||||||||||
|
Name
|
| |
Number of
Securities Underlying Unexercised Options (#) Exercisable |
| |
Number of
Securities Underlying Unexercised Options (#) Unexercisable |
| |
Option
Exercise Price ($) |
| |
Option
Expiration Date |
| ||||||||||||
|
Serhii Kupriienko
|
| | | | 3,292,275 | | | | | | 2,351,625 | | | | | $ | 0.00001 | | | | | | 09/14/2033 | | |
|
Alexander Fink(2)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Position
|
| |
Retainer
|
| |||
|
Board Member
|
| | | $ | 40,000 | | |
|
Board Chairperson
|
| | | $ | — | | |
|
Audit Committee Chair
|
| | | $ | 15,000 | | |
|
Compensation Committee Chair
|
| | | $ | 10,000 | | |
|
Nominating and Corporate Governance Committee Chair
|
| | | $ | 10,000 | | |
|
Audit Committee Member
|
| | | $ | 7,500 | | |
|
Compensation Committee Member
|
| | | $ | 5,000 | | |
|
Nominating and Corporate Governance Committee Member
|
| | | $ | 5,000 | | |
|
Name
|
| |
Shares of
Series A-1 Convertible Preferred Stock Purchased |
| |
Aggregate
Purchase Price |
| ||||||
|
Theseus Capital Partners, LLC(1)
|
| | | | 597,980 | | | | | $ | 3,749,992 | | |
|
RG.AI Technologies, Inc.
|
| | | | 194,805 | | | | | $ | 1,221,642 | | |
|
D3 Fund, LP
|
| | | | 139,939 | | | | | $ | 877,575 | | |
|
Green Flag Fund I, L.P.(2)
|
| | | | 74,380 | | | | | $ | 466,444 | | |
|
Name
|
| |
Shares of
Series A-2 Convertible Preferred Stock Received upon Conversion of SAFEs |
| |||
|
D3 Fund, LP
|
| | | | 223,336 | | |
|
Name
|
| |
Shares of
Series A-4 Convertible Preferred Stock Received upon Conversion of SAFEs |
| |||
|
RG.AI Technologies, Inc.
|
| | | | 501,166 | | |
|
D3 Fund, LP
|
| | | | 136,681 | | |
|
Green Flag Fund I, L.P.
|
| | | | 191,354 | | |
|
Radius Fund I, L.P.
|
| | | | 341,704 | | |
| | | |
Shares
Beneficially Owned |
| |
Percentage of Shares
Beneficially Owned |
| ||||||||||||
|
Name and Address of Beneficial Owner(1)
|
| |
Before
Offering |
| |
After
Offering |
| ||||||||||||
| Greater than 5% Stockholders: | | | | | | | | | | | | | | | | | | | |
|
Theseus Capital Partners, LLC(2)
|
| | | | 2,324,961 | | | | | | 22.0% | | | | | | 17.2% | | |
|
D3 Fund, LP(3)
|
| | | | 940,569 | | | | | | 10.1% | | | | | | 7.6% | | |
|
RG.AI Technologies, Inc.(4)
|
| | | | 1,309,331 | | | | | | 14.0% | | | | | | 10.6% | | |
|
Green Flag Fund I, L.P.(5)
|
| | | | 499,927 | | | | | | 5.3% | | | | | | 4.0 | | |
|
Radius Fund I, L.P.(6)
|
| | | | 642,848 | | | | | | 6.9% | | | | | | 5.2 | | |
| Named Executive Officers and Directors: | | | | | | | | | | | | | | | | | | | |
|
Serhii Kupriienko(7)
|
| | | | 1,875,000 | | | | | | 27.4% | | | | | | 22.2% | | |
|
Alexander Fink(8)
|
| | | | 1,410,975 | | | | | | 15.1% | | | | | | 11.4% | | |
|
Erik Prince(9)
|
| | | | — | | | | | | —% | | | | | | —% | | |
|
Philip Wagenheim(10)
|
| | | | 2,324,961 | | | | | | 22.0% | | | | | | 17.2% | | |
|
Justin Zeefe(11)
|
| | | | 499,927 | | | | | | 5.3% | | | | | | 4.0% | | |
|
Edward Antoian(12)
|
| | | | — | | | | | | —% | | | | | | —% | | |
|
Amir Frenkel(13)
|
| | | | — | | | | | | —% | | | | | | —% | | |
|
Derek Reisfield(14)
|
| | | | — | | | | | | —% | | | | | | —% | | |
|
All current executive officers and directors as a group (10 persons)(15)
|
| | | | 7,763,301 | | | | | | 55.2% | | | | | | 45.5% | | |
|
Underwriter
|
| |
Number of
shares |
| |||
|
Lucid Capital Markets, LLC
|
| | | | 3,000,000 | | |
|
Total
|
| | | | 3,000,000 | | |
| | | |
Effective
Price Per Share |
| |
Total
Without Option |
| |
Total
With Option |
| |||||||||
|
Public offering price
|
| | | $ | 5.00 | | | | | $ | 15,000,000 | | | | | $ | 17,250,000 | | |
|
Underwriting discounts and commissions payable by us, before expenses, to us(1)
|
| | | $ | 0.30 | | | | | $ | 900,000 | | | | | $ | 1,035,000 | | |
|
Proceeds, before expenses, to us
|
| | | $ | 4.70 | | | | | $ | 14,100,000 | | | | | $ | 16,215,000 | | |
| | | |
Page
|
| |||
| | | | | F-2 | | | |
| | | | | F-3 | | | |
| | | | | F-4 | | | |
| | | | | F-5 | | | |
| | | | | F-6 | | | |
| | | | | F-7 | | | |
| | | |
December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
| Assets | | | | | | | | | | | | | |
| Current assets: | | | | | | | | | | | | | |
|
Cash and cash equivalents
|
| | | $ | 9,283,566 | | | | | $ | 2,081,086 | | |
|
Unbilled revenue
|
| | | | — | | | | | | 11,939 | | |
|
Prepaid expenses and other current assets
|
| | | | 115,473 | | | | | | 49,477 | | |
|
Total current assets
|
| | | | 9,399,039 | | | | | | 2,142,502 | | |
|
Property and equipment, net
|
| | | | 227,908 | | | | | | 5,401 | | |
|
Operating lease right-of-use asset
|
| | | | 131,184 | | | | | | — | | |
|
Deferred offering costs
|
| | | | 471,719 | | | | | | — | | |
|
Other assets
|
| | | | 106,830 | | | | | | — | | |
|
Total assets
|
| | | $ | 10,336,680 | | | | | $ | 2,147,903 | | |
| Liabilities, convertible preferred stock and shareholders’ deficit | | | | | | | | | | | | | |
| Current liabilities: | | | | | | | | | | | | | |
|
Accounts payable
|
| | | $ | 223,236 | | | | | $ | 974 | | |
|
Accrued expenses and other current liabilities
|
| | | | 680,782 | | | | | | 203,605 | | |
|
Grant advance
|
| | | | 189,200 | | | | | | 47,540 | | |
|
Deferred revenue
|
| | | | 23,272 | | | | | | — | | |
|
Operating lease liability – current
|
| | | | 70,703 | | | | | | — | | |
|
Total current liabilities
|
| | | | 1,187,193 | | | | | | 252,119 | | |
|
Operating lease liability – non-current
|
| | | | 76,273 | | | | | | — | | |
|
SAFE liability, fair value
|
| | | | — | | | | | | 3,965,000 | | |
|
Total liabilities
|
| | | | 1,263,466 | | | | | | 4,217,119 | | |
| Convertible preferred stock, par value $0.00001 per share: | | | | | | | | | | | | | |
|
Series A preferred stock: 4,358,597 shares authorized; 3,661,083 shares issued and outstanding at December 31, 2025 (Liquidation value of $15.3 million at December 31, 2025)
|
| | | | 19,013,673 | | | | | | — | | |
| Commitments and contingencies (Note 7) | | | | | | | | | | | | | |
| Shareholders’ deficit | | | | | | | | | | | | | |
|
Common stock, par value $0.00001 per share; 25,000,000 shares
authorized; 1,410,975 shares issued and 911,255 and 558,511 outstanding at December 31, 2025 and 2024, respectively |
| | | | 10 | | | | | | 6 | | |
|
Additional paid-in capital
|
| | | | 663,514 | | | | | | 1,207 | | |
|
Accumulated other comprehensive loss
|
| | | | (4,900) | | | | | | (609) | | |
|
Accumulated deficit
|
| | | | (10,599,083) | | | | | | (2,069,820) | | |
|
Total shareholders’ deficit
|
| | | | (9,940,459) | | | | | | (2,069,216) | | |
|
Total liabilities, convertible preferred stock and shareholders’ deficit
|
| | | $ | 10,336,680 | | | | | $ | 2,147,903 | | |
| | | |
Years Ended December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
|
Revenue
|
| | | $ | 309,920 | | | | | $ | 329,410 | | |
|
Cost of revenue
|
| | | | 182,163 | | | | | | 187,848 | | |
|
Gross margin
|
| | | | 127,757 | | | | | | 141,562 | | |
| Operating expenses: | | | | | | | | | | | | | |
|
Selling, general and administrative
|
| | | | 2,665,004 | | | | | | 368,795 | | |
|
Research and development
|
| | | | 2,578,860 | | | | | | 1,011,498 | | |
|
Total operating expenses
|
| | | | 5,243,864 | | | | | | 1,380,293 | | |
|
Loss from operations
|
| | | | (5,116,107) | | | | | | (1,238,731) | | |
| Other income (expense): | | | | | | | | | | | | | |
|
Change in fair value of SAFE liability
|
| | | | (3,493,431) | | | | | | (829,700) | | |
|
Other income
|
| | | | 80,275 | | | | | | 524 | | |
|
Loss before income taxes
|
| | | | (8,529,263) | | | | | | (2,067,907) | | |
|
Income tax expense
|
| | | | — | | | | | | (1,735) | | |
|
Net loss
|
| | | $ | (8,529,263) | | | | | $ | (2,069,642) | | |
|
Net loss per share of common stock, basic and diluted
|
| | | $ | (2.46) | | | | | $ | (2.68) | | |
|
Weighted-average shares of common stock outstanding, basic and diluted
|
| | | | 3,461,565 | | | | | | 772,351 | | |
| Comprehensive loss: | | | | | | | | | | | | | |
|
Foreign currency translation adjustments
|
| | | | (4,291) | | | | | | (609) | | |
|
Total comprehensive loss
|
| | | $ | (8,533,554) | | | | | $ | (2,070,251) | | |
| | | |
Series A
Convertible Preferred Stock |
| | |
Common Stock
|
| |
Additional
Paid In Capital |
| |
Accumulated
Other Comprehensive Loss |
| |
Accumulated
Deficit |
| |
Total
|
| ||||||||||||||||||||||||||||||
| | | |
Shares
|
| |
Amount
|
| | |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||
|
Balance at January 1, 2024
|
| | |
|
—
|
| | | |
|
—
|
| | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | — | | | | | | (178) | | | | | | (178) | | |
|
Contributions from owners
|
| | |
|
—
|
| | | |
|
—
|
| | | | |
|
—
|
| | | |
|
—
|
| | | | | 1,213 | | | | | | — | | | | | | — | | | | | | 1,213 | | |
|
Issuance of common stock on vesting of restricted stock awards
|
| | | | — | | | | | | — | | | | | | | 558,511 | | | | | | 6 | | | | | | (6) | | | | | | — | | | | | | — | | | | | | — | | |
|
Foreign currency translation adjustments
|
| | |
|
—
|
| | | |
|
—
|
| | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | (609) | | | | | | — | | | | | | (609) | | |
|
Net loss
|
| | |
|
—
|
| | | |
|
—
|
| | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | — | | | | | | (2,069,642) | | | | | | (2,069,642) | | |
|
Balance at December 31, 2024
|
| | | | — | | | | | | — | | | | | | | 558,511 | | | | | | 6 | | | | | | 1,207 | | | | | | (609) | | | | | | (2,069,820) | | | | | | (2,069,216) | | |
|
Sale of Series A convertible preferred stock and common stock warrants, net of issuance costs
|
| | | | 1,933,605 | | | | | | 11,525,242 | | | | | | | — | | | | | | — | | | | | | 467,568 | | | | | | — | | | | | | — | | | | | | 467,568 | | |
|
Conversion of SAFEs into Series A convertible preferred stock
|
| | | | 1,727,478 | | | | | | 7,488,431 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Issuance of common stock on vesting of restricted stock awards
|
| | | | — | | | | | | — | | | | | | | 352,744 | | | | | | 4 | | | | | | (4) | | | | | | — | | | | | | — | | | | | | — | | |
|
Share-based compensation
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 194,743 | | | | | | — | | | | | | — | | | | | | 194,743 | | |
|
Foreign currency translation adjustments
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | (4,291) | | | | | | — | | | | | | (4,291) | | |
|
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (8,529,263) | | | | | | (8,529,263) | | |
|
Balance at December 31, 2025
|
| | | | 3,661,083 | | | | | $ | 19,013,673 | | | | | | | 911,255 | | | | | $ | 10 | | | | | $ | 663,514 | | | | | $ | (4,900) | | | | | $ | (10,599,083) | | | | | $ | (9,940,459) | | |
| | | |
Years Ended December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
| Operating activities: | | | | | | | | | | | | | |
|
Net loss
|
| | | $ | (8,529,263) | | | | | $ | (2,069,642) | | |
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | | | | | | |
|
Depreciation expense
|
| | | | 23,460 | | | | | | 3,503 | | |
|
Amortization of ROU asset
|
| | | | 15,566 | | | | | | — | | |
|
Change in fair value of SAFE liability
|
| | | | 3,493,431 | | | | | | 829,700 | | |
|
Share-based compensation expense
|
| | | | 194,743 | | | | | | — | | |
|
Changes in operating assets and liabilities:
|
| | | | | | | | | | | | |
|
Unbilled revenue
|
| | | | 12,342 | | | | | | (12,342) | | |
|
Prepaid expenses and other current assets
|
| | | | (65,953) | | | | | | (49,956) | | |
|
Other assets
|
| | | | (106,935) | | | | | | — | | |
|
Accounts payable
|
| | | | 222,258 | | | | | | 983 | | |
|
Accrued expenses and other liabilities
|
| | | | (49,843) | | | | | | 203,628 | | |
|
Grant advance
|
| | | | 144,000 | | | | | | 48,000 | | |
|
Deferred revenue
|
| | | | 23,617 | | | | | | — | | |
|
Operating lease liability
|
| | | | 226 | | | | | | — | | |
|
Net cash used in operating activities
|
| | | | (4,622,351) | | | | | | (1,046,126) | | |
| Investing activities: | | | | | | | | | | | | | |
|
Purchase of property and equipment
|
| | | | (246,993) | | | | | | (8,956) | | |
|
Cash used in investing activities
|
| | | | (246,993) | | | | | | (8,956) | | |
| Financing activities: | | | | | | | | | | | | | |
|
Proceeds from issuance of SAFE liability
|
| | | | 30,000 | | | | | | 3,010,300 | | |
|
Proceeds from sale of convertible preferred stock and common stock warrants
|
| | | | 12,125,830 | | | | | | — | | |
|
Payment of financing costs
|
| | | | (77,739) | | | | | | 1,213 | | |
|
Cash provided by financing activities
|
| | | | 12,078,091 | | | | | | 3,011,513 | | |
|
Effect of exchange rates on cash and cash equivalents
|
| | | | (6,267) | | | | | | (167) | | |
|
Net increase in cash and cash equivalents
|
| | | | 7,202,480 | | | | | | 1,956,264 | | |
|
Cash and cash equivalents at the beginning of the period
|
| | | | 2,081,086 | | | | | | 124,822 | | |
|
Cash and cash equivalents at the end of the period
|
| | | $ | 9,283,566 | | | | | $ | 2,081,086 | | |
| Supplemental non-cash investing and financing activities: | | | | | | | | | | | | | |
|
Right-of-use assets obtained in exchange for operating lease obligations
|
| | | $ | 146,750 | | | | | $ | — | | |
|
Deferred offering costs in accounts payable and accrued expenses
|
| | | $ | 461,000 | | | | | $ | — | | |
|
Financing costs in accrued expenses
|
| | | $ | 66,000 | | | | | $ | — | | |
|
Issuance of preferred stock upon conversion of SAFEs
|
| | | $ | 7,488,431 | | | | | $ | — | | |
| | | |
December 31, 2024
|
| |||||||||||||||||||||
| | | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total Fair Value
|
| ||||||||||||
| Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
|
SAFE Liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 3,965,000 | | | | | $ | 3,965,000 | | |
|
Total liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 3,965,000 | | | | | $ | 3,965,000 | | |
| | | |
SAFE
Liability |
| |||
|
Balance at January 1, 2024
|
| | | $ | 125,000 | | |
|
Additions
|
| | | | 3,010,300 | | |
|
Change in fair value
|
| | | | 829,700 | | |
|
Balance at December 31, 2024
|
| | | | 3,965,000 | | |
|
Additions
|
| | | | 30,000 | | |
|
Change in fair value
|
| | | | 3,493,431 | | |
|
Conversion into convertible preferred stock
|
| | | | (7,488,431) | | |
|
Balance at December 31, 2025
|
| | | $ | — | | |
| |
Multiple scenarios expected term (in years)
|
| | | | 2.80 | | |
| |
Probability of initial public offering
|
| | | | 40% | | |
| |
Probability of stay private
|
| | | | 60% | | |
| |
Equity volatility
|
| | | | 59% | | |
| |
Risk-free rate
|
| | | | 3.5% | | |
| |
Discount rate
|
| | | | 14.1% | | |
| |
Multiple scenarios expected term (in years)
|
| | | | 1.00 | | |
| |
Probability of equity financing
|
| | | | 65% | | |
| |
Probability of liquidity event
|
| | | | 30% | | |
| |
Probability of event of default
|
| | | | 50% | | |
| | | |
December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
|
Consulting and professional fees
|
| | | $ | 635,678 | | | | | $ | 184,252 | | |
|
Compensation
|
| | | | 13,272 | | | | | | — | | |
|
Research and development
|
| | | | — | | | | | | 11,981 | | |
|
Other
|
| | | | 31,832 | | | | | | 7,372 | | |
| | | | | $ | 680,782 | | | | | $ | 203,605 | | |
| |
2026
|
| | | $ | 75,594 | | |
| |
2027
|
| | | | 77,860 | | |
| |
Total lease payments
|
| | | | 153,454 | | |
| |
Less: present value adjustment
|
| | | | 6,478 | | |
| |
Total lease liabilities
|
| | | $ | 146,976 | | |
| | | |
Years Ended December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
|
Performance obligations satisfied at point in time
|
| | | $ | 176,230 | | | | | $ | 267,945 | | |
|
Performance obligations satisfied over time
|
| | | | 133,690 | | | | | | 61,465 | | |
|
Total
|
| | | $ | 309,920 | | | | | $ | 329,410 | | |
| | | |
Years Ended December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
|
Balance, beginning of year
|
| | | $ | — | | | | | $ | — | | |
|
Deferral of revenue
|
| | | | 333,192 | | | | | | 329,410 | | |
|
Recognition of unearned revenue
|
| | | | (309,920) | | | | | | (329,410) | | |
|
Balance, end of year
|
| | | $ | 23,272 | | | | | $ | — | | |
| |
Stock price per share
|
| | | $ | 1.68 | | |
| |
Term (years)
|
| | | | 1.50 | | |
| |
Volatility
|
| | | | 59.0% | | |
| |
Dividend yield
|
| | | | 0.0% | | |
| |
Risk-free interest rate
|
| | | | 3.5% | | |
| | | |
Authorized
Shares |
| |
Issued and
Outstanding Shares |
| |
Liquidation
Value |
| |
Carrying
Value |
| ||||||||||||
|
Series A-1
|
| | | | 2,631,119 | | | | | | 1,933,605 | | | | | $ | 12,125,830 | | | | | $ | 11,525,242 | | |
|
Series A-2
|
| | | | 223,336 | | | | | | 223,336 | | | | | | 125,000 | | | | | | 844,210 | | |
|
Series A-3
|
| | | | 223,246 | | | | | | 223,246 | | | | | | 209,999 | | | | | | 880,929 | | |
|
Series A-4
|
| | | | 1,262,162 | | | | | | 1,262,162 | | | | | | 2,770,293 | | | | | | 5,670,894 | | |
|
Series A-5
|
| | | | 12,756 | | | | | | 12,756 | | | | | | 29,998 | | | | | | 58,180 | | |
|
Series A-6
|
| | | | 5,978 | | | | | | 5,978 | | | | | | 29,991 | | | | | | 34,218 | | |
|
Total
|
| | | | 4,358,597 | | | | | | 3,661,083 | | | | | $ | 15,291,111 | | | | | $ | 19,013,673 | | |
| | | |
Number of
Shares |
| |
Weighted
Average Exercise Price |
| |
Weighted
Average Remaining Contractual Term (years) |
| |||||||||
|
Outstanding at January 1, 2024
|
| | | | 5,643,900 | | | | | $ | 0.00 | | | | | | | | |
|
Granted
|
| | | | 752,520 | | | | | $ | 0.00 | | | | | | | | |
|
Outstanding at December 31, 2024
|
| | | | 6,396,420 | | | | | $ | 0.00 | | | | | | | | |
|
Granted
|
| | | | 2,686,075 | | | | | $ | 3.09 | | | | | | | | |
|
Forfeited
|
| | | | (9,521) | | | | | $ | 0.67 | | | | | | | | |
|
Outstanding at December 31, 2025
|
| | | | 9,072,974 | | | | | $ | 0.91 | | | | | | 9.05 | | |
|
Vested and Exercisable at December 31, 2025
|
| | | | 3,831,951 | | | | | $ | 0.16 | | | | | | 7.87 | | |
| |
Expected volatility
|
| | | | 50.3% | | |
| |
Risk-free interest rate
|
| | | | 3.7% | | |
| |
Expected term (in years)
|
| | | | 5.9 | | |
| |
Expected dividend yield
|
| | | | 0.0% | | |
| | | | | | | | | |
Weighted Average
Grant Date Fair Value |
| |||
|
Unvested at January 1, 2024
|
| | | | 1,410,975 | | | | | $ | 0.00 | | |
|
Vested
|
| | | | (558,511) | | | | | $ | 0.00 | | |
|
Unvested at December 31, 2024
|
| | | | 852,464 | | | | | $ | 0.00 | | |
|
Vested
|
| | | | (352,744) | | | | | $ | 0.00 | | |
|
Unvested at December 31, 2025
|
| | | | 499,720 | | | | | $ | 0.00 | | |
| | | |
December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
|
Convertible preferred stock
|
| | | | 6,887,620 | | | | | | — | | |
|
Common stock warrants
|
| | | | 2,999,950 | | | | | | — | | |
|
Unvested restricted stock awards
|
| | | | 499,720 | | | | | | 852,464 | | |
|
Stock options
|
| | | | 5,474,986 | | | | | | 4,397,540 | | |
| | | | | | 15,862,276 | | | | | | 5,250,004 | | |
| | | |
Years Ended December 31,
|
| |||||||||||||||||||||
| | | |
2025
|
| |
2024
|
| ||||||||||||||||||
|
U.S. Statutory Tax Rate
|
| | | | (1,791,145) | | | | | | 21.0% | | | | | | (434,260) | | | | | | 21.0% | | |
|
State and Local Income Taxes, Net of Federal Income Tax
Effect* |
| | | | (259,769) | | | | | | 3.0% | | | | | | (86,655) | | | | | | 4.2% | | |
|
Foreign Tax Effects
|
| | | | — | | | | | | | | | | | | — | | | | | | | | |
|
Ukraine
|
| | | | — | | | | | | | | | | | | — | | | | | | | | |
|
Statutory tax rate difference between Ukraine and United States
|
| | | | 8,964 | | | | | | -0.1% | | | | | | (289) | | | | | | -0.1% | | |
|
Change in valuation allowance
|
| | | | 53,786 | | | | | | -0.6% | | | | | | — | | | | | | 0.0% | | |
|
Other
|
| | | | — | | | | | | 0.0% | | | | | | — | | | | | | 0.0% | | |
|
Estonia
|
| | | | — | | | | | | 0.0% | | | | | | — | | | | | | 0.0% | | |
|
Statutory tax rate difference between Estonia and United States
|
| | | | (7,983) | | | | | | 0.1% | | | | | | — | | | | | | 0.0% | | |
|
Change in valuation allowance
|
| | | | 175,636 | | | | | | -2.1% | | | | | | — | | | | | | 0.0% | | |
|
Other
|
| | | | — | | | | | | 0.0% | | | | | | — | | | | | | 0.0% | | |
|
Effect of Changes in Tax Laws or Rates Enacted in the Current Period
|
| | | | — | | | | | | 0.0% | | | | | | — | | | | | | 0.0% | | |
|
Effect of Cross-Border Tax Laws
|
| | | | — | | | | | | 0.0% | | | | | | — | | | | | | 0.0% | | |
|
U.S. Federal R&D Tax Credits
|
| | | | (118,280) | | | | | | 1.4% | | | | | | (6,606) | | | | | | 0.3% | | |
|
Change in Valuation Allowances
|
| | | | 1,171,755 | | | | | | -13.7% | | | | | | 358,029 | | | | | | -17.1% | | |
|
Nontaxable or Nondeductible Items
|
| | | | 33,416 | | | | | | -0.4% | | | | | | (2,721) | | | | | | 0.1% | | |
|
Changes in Unrecognized Tax Benefits
|
| | | | — | | | | | | 0.0% | | | | | | — | | | | | | 0.0% | | |
|
Other Adjustments
|
| | | | — | | | | | | | | | | | | — | | | | | | | | |
|
Change in FV of SAFE Liability
|
| | | | 733,620 | | | | | | -8.6% | | | | | | 174,237 | | | | | | -8.4% | | |
|
Actual income tax benefit effective tax rate
|
| | | | — | | | | | | 0.0% | | | | | | 1,735 | | | | | | 0.0% | | |
| | | |
Years Ended December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
| Deferred tax assets: | | | | | | | | | | | | | |
|
Net operating loss carryforwards
|
| | | $ | 1,355,370 | | | | | $ | 261,570 | | |
|
Accruals and other
|
| | | | 246,023 | | | | | | 64,374 | | |
|
Capitalized research and development expenditures
|
| | | | 19,853 | | | | | | 25,528 | | |
|
Research and development tax credits
|
| | | | 124,886 | | | | | | 6,606 | | |
|
Lease liabilities
|
| | | | 40,967 | | | | | | — | | |
|
Share-based compensation
|
| | | | 11,706 | | | | | | — | | |
|
Total deferred tax assets
|
| | | | 1,798,804 | | | | | | 358,078 | | |
|
Less: valuation allowance
|
| | | | (1,759,255) | | | | | | (358,078) | | |
|
Deferred tax asset, net of valuation allowance
|
| | | $ | 39,548 | | | | | $ | — | | |
| Deferred tax liabilities: | | | | | | | | | | | | | |
|
Depreciation and amortization
|
| | | | (2,983) | | | | | | — | | |
|
Right-of-use assets
|
| | | | (36,565) | | | | | | — | | |
|
Total deferred tax liabilities
|
| | | | (39,548) | | | | | | — | | |
|
Net deferred tax assets:
|
| | | $ | — | | | | | $ | — | | |
| | | |
Years Ended December 31,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
|
Revenue
|
| | | $ | 309,920 | | | | | $ | 329,410 | | |
|
Cost of revenue
|
| | | | 182,163 | | | | | | 187,848 | | |
|
Gross margin
|
| | | | 127,757 | | | | | | 141,562 | | |
| Operating expenses: | | | | | | | | | | | | | |
|
Professional fees and consultants
|
| | | | 4,237,050 | | | | | | 1,097,942 | | |
|
Research and development
|
| | | | 276,375 | | | | | | 118,036 | | |
|
General and administrative
|
| | | | 699,576 | | | | | | 164,109 | | |
|
Sales and marketing
|
| | | | 30,863 | | | | | | 206 | | |
|
Total operating expenses
|
| | | | 5,243,864 | | | | | | 1,380,293 | | |
|
Change in fair value of SAFE liability
|
| | | | 3,493,431 | | | | | | 829,700 | | |
|
Other income
|
| | | | (80,275) | | | | | | (524) | | |
|
Loss before income taxes
|
| | | | (8,529,263) | | | | | | (2,067,907) | | |
|
Income tax expense
|
| | | | — | | | | | | (1,735) | | |
|
Segment net loss
|
| | | $ | (8,529,263) | | | | | $ | (2,069,642) | | |
| |
Series A-1:
|
| | | | 3.3334 | | |
| |
Series A-2:
|
| | | | 0.2975 | | |
| |
Series A-3:
|
| | | | 0.5000 | | |
| |
Series A-4:
|
| | | | 1.1667 | | |
| |
Series A-5:
|
| | | | 1.2499 | | |
| |
Series A-6:
|
| | | | 2.6663 | | |